SCD for CRS in Congestive Heart Failure (CHF) (No Left Ventricular Assist Device)
NCT04589065 · Status: SUSPENDED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10
Last updated 2024-09-27
Summary
The purpose of this clinical trial is to see if a new device (SCD) is safe and if it can reduce damage to the kidney enough to allow medications to work to improve heart and kidney function for use in patients that have moderate to severe heart failure and is at least in part due to heart failure and it not responding to standard medical therapy. The SCD is a cartridge used with a commercial hemodialysis unit.
Participants will be enrolled in the clinical trial once eligibility is confirmed. In addition to clinical assessments and laboratory testing participants will have surface echocardiograms during the trial. The SCD treatment will take place for 4 hours on day 1, 3, and 5 while on hemodialysis.
Conditions
- Heart Failure
- Chronic Systolic Heart Failure
- Renal Failure
- Cardiorenal Syndrome
Interventions
- DEVICE
-
Selective Cytopheretic Device
SCD therapy will take place for 4 hours on day 1, 3, and 5 while on hemodialysis treatment. Participants will be continue to be followed until 30 days after the last SCD treatment.
Sponsors & Collaborators
-
Lenar Yessayan
lead OTHER
Principal Investigators
-
Keith Aaronson, MD · University of Michigan
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 21 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-09-30
- Primary Completion
- 2027-12-31
- Completion
- 2027-12-31
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
An Automated Continual Water Removal System in Patients With Advanced Diuretic Resistant Heart Failure
NCT05140759 ·Status: TERMINATED ·Phase: NA
-
Feasibility of the AccuCinch® System for Left Ventricular Reshaping of the Mitral Apparatus to Reduce Functional Mitral Regurgitation and Improve Left Ventricular Function
NCT02153892 ·Status: COMPLETED ·Phase: NA
-
Study of Percutaneous Renal Artery Intervention for Patient With Heart Failure
NCT01403714 ·Status: WITHDRAWN ·Phase: NA
-
Safety Study of the Ventricular Partitioning Device (VPD) Implant System in Heart Failure Patients
NCT00573560 ·Status: COMPLETED ·Phase: PHASE1
-
Assess Safety and Probable Benefit of the EXCOR® Pediatric Ventricular Assist Device
NCT00583661 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the HeartWare Left Ventricular Assist Device for the Treatment of Advanced Heart Failure
NCT00751972 ·Status: COMPLETED ·Phase: NA
-
Early Feasibility Evaluation of the AccuCinch® Ventricular Restoration System in Patients With Heart Failure and Reduced Ejection Fraction
NCT03533517 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Investigation of the Safety and Feasibility of AAV1/SERCA2a Gene Transfer in Patients With Chronic Heart Failure
NCT00534703 ·Status: TERMINATED ·Phase: PHASE2
-
ALLEVIATE-HFrEF Study
NCT05133089 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of the Safety and Effectiveness of the DuraHeart™ LVAS
NCT00710567 ·Status: TERMINATED ·Phase: NA
-
Extended IASD Investigation: REDUCE LAP-HF IV
NCT04632160 ·Status: WITHDRAWN ·Phase: NA
-
Corheart 6 LVAS Study
NCT05876000 ·Status: RECRUITING ·Phase: NA
-
Left Ventricular Assist Device Combined With Allogeneic Mesenchymal Stem Cells Implantation in Patients With End-stage Heart Failure.
NCT01759212 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
The V-Wave Shunt: FIM Safety and Feasibility Study
NCT01965015 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in High Risk and Very High Risk Subjects Who Need Aortic Valve Replacement
NCT01240902 ·Status: COMPLETED ·Phase: NA
-
CorMatrix Cor TRICUSPID ECM Valve Replacement Study
NCT02397668 ·Status: RECRUITING ·Phase: NA
-
ImCardia for DHF to Treat Diastolic Heart Failure (DHF) Patient a Pilot Study
NCT01347125 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Effect of HCO1100 on Cardiovascular Function
NCT01363921 ·Status: TERMINATED ·Phase: NA
-
Study Assessing Left Ventricular Administration of a Genetic Medicine Directing Organ Regeneration in Heart Failure
NCT06831825 ·Status: RECRUITING ·Phase: PHASE1
-
AAV1-CMV-Serca2a GENe Therapy Trial in Heart Failure
NCT01966887 ·Status: TERMINATED ·Phase: PHASE2
-
LVAD in Non Cardiac Transplant Candidates and Non Responders to Resynchronization
NCT01126944 ·Status: WITHDRAWN ·Phase: NA
-
Conservative Management of Left Ventricular Assist Device Candidates
NCT05271214 ·Status: RECRUITING
-
A Pivotal Trial to Establish the Efficacy and Long-term Safety of the Parachute Implant System
NCT01614652 ·Status: TERMINATED ·Phase: PHASE3
-
Corheart 6 Left Ventricular Assist System Prospective, Multicenter, Single-arm Clinical Evaluation Trial
NCT05353816 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The HeartWare™ Ventricular Assist System as Destination Therapy of Advanced Heart Failure: the ENDURANCE Trial
NCT01166347 ·Status: COMPLETED ·Phase: NA